Birdwatch Note Rating
2024-03-01 13:58:25 UTC - HELPFUL
Rated by Participant: DAB072FD992B32C25AB11D97A5247011EC2AED0CA5BFFA0D8436A9DE758ACD29
Participant Details
Original Note:
This news, from November, pertains to a gene therapy treatment for a type of cancer (not COVID-19). The FDA press release specifically notes the benefits of the treatment continue to outweigh the risks. https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/fda-investigating-serious-risk-t-cell-malignancy-following-bcma-directed-or-cd19-directed-autologous
All Note Details